Higher Tech Lowers Cost Of Genetic Screening

By Andrew Tobin

Published August 03, 2011, issue of August 12, 2011.
  • Print
  • Share Share

Screening for genetic disorders has come a long way since the first tests for Tay-Sachs disease in the late 1960s. At the time, clinicians screened the Jewish community by measuring enzyme levels in people’s blood. But in the late 1980s, newer genetic tests became available for Tay-Sachs and, soon after, for a range of other so-called “Jewish genetic diseases” including Canavan disease, cystic fibrosis and Fanconi anemia.

The DNA-based tests were more specific, allowing for more reliable diagnoses of whether people harbored rare recessive mutations. But the tests were also more expensive: Testing for each disease generally cost between $100 and $500, depending on the number of mutations inspected.

As the number of diseases included in community screens grew, so did the price tag for testing. And with more than a dozen diseases now routinely tested, commercial labs often charge thousands of dollars for the whole lot, and insurance companies vary on the degree of reimbursement.

New technologies, however, are bringing down the sticker price of genetic disease screening. Unlike older approaches — which were often laborious and time-consuming, requiring lab technicians to test for individual mutations one by one, in piecemeal fashion — most laboratory work is now automated, with many different genetic tests conducted in parallel on a single “gene chip.” As such, screening for the full panel of Ashkenazi Jewish disease can now cost as little as a single DNA test for Tay-Sachs did 20 years ago.

Already, several academic laboratories, including those at the Jacobi and Mount Sinai medical centers, have implemented the chip-based technologies in Jewish community screens around the New York area (although they continue to use enzyme-based assays in tandem with newer DNA methods to screen specifically for Tay-Sachs).

One of the first commercial companies to market the cheaper DNA approach is Counsyl, a startup based in California’s Silicon Valley. The preventive carrier-screening company now provides testing for 18 Ashkenazi Jewish diseases at $349, and plans to add Walker-Warburg syndrome to its panel later this summer.

However, gene chip methods may soon be supplanted by the latest DNA sequencing technologies. According to Counsyl’s president, Balaji Srinivasan, the company soon plans to offer full DNA readouts for nearly 100 diseases, including a dozen that are particularly common among Ashkenazi Jews. Counsyl has not yet priced the test, but Srinivasan said it will cost about as much as the current Jewish panel.

At that point, deciding what test to use will pose more of an epistemic than a financial dilemma, experts say. “Next-generation sequencing shows mutations that are less strongly correlated with disease,” said Dr. Susan Gross, director of the Program for Jewish Genetic Health at Yeshiva University. “So people have to ask themselves how much they want to know.”

Contact Andrew Tobin at tobin@forward.com


The Jewish Daily Forward welcomes reader comments in order to promote thoughtful discussion on issues of importance to the Jewish community. In the interest of maintaining a civil forum, The Jewish Daily Forwardrequires that all commenters be appropriately respectful toward our writers, other commenters and the subjects of the articles. Vigorous debate and reasoned critique are welcome; name-calling and personal invective are not. While we generally do not seek to edit or actively moderate comments, our spam filter prevents most links and certain key words from being posted and The Jewish Daily Forward reserves the right to remove comments for any reason.





Find us on Facebook!
  • The rose petals have settled, and Andi has made her (Jewish?) choice. We look back on the #Bachelorette finale:
  • "Despite the great pain and sadness surrounding a captured soldier, this should not shape the face of this particular conflict – not in making concessions and not in negotiations, not in sobering assessments of this operation’s achievements or the need to either retreat or move forward." Do you agree?
  • Why genocide is always wrong, period. And the fact that some are talking about it shows just how much damage the war in Gaza has already done.
  • Construction workers found a 75-year-old deli sign behind a closing Harlem bodega earlier this month. Should it be preserved?
  • "The painful irony in Israel’s current dilemma is that it has been here before." Read J.J. Goldberg's latest analysis of the conflict:
  • Law professor Dan Markel waited a shocking 19 minutes for an ambulance as he lay dying after being ambushed in his driveway. Read the stunning 911 transcript as neighbor pleaded for help.
  • Happy birthday to the Boy Who Lived! July 31 marks the day that Harry Potter — and his creator, J.K. Rowling — first entered the world. Harry is a loyal Gryffindorian, a matchless wizard, a native Parseltongue speaker, and…a Jew?
  • "Orwell would side with Israel for building a flourishing democracy, rather than Hamas, which imposed a floundering dictatorship. He would applaud the IDF, which warns civilians before bombing them in a justified war, not Hamas terrorists who cower behind their own civilians, target neighboring civilians, and planned to swarm civilian settlements on the Jewish New Year." Read Gil Troy's response to Daniel May's opinion piece:
  • "My dear Penelope, when you accuse Israel of committing 'genocide,' do you actually know what you are talking about?"
  • What's for #Shabbat dinner? Try Molly Yeh's coconut quinoa with dates and nuts. Recipe here:
  • Can animals suffer from PTSD?
  • Is anti-Zionism the new anti-Semitism?
  • "I thought I was the only Jew on a Harley Davidson, but I was wrong." — Gil Paul, member of the Hillel's Angels. http://jd.fo/g4cjH
  • “This is a dangerous region, even for people who don’t live there and say, merely express the mildest of concern about the humanitarian tragedy of civilians who have nothing to do with the warring factions, only to catch a rash of *** (bleeped) from everyone who went to your bar mitzvah! Statute of limitations! Look, a $50 savings bond does not buy you a lifetime of criticism.”
  • from-cache

Would you like to receive updates about new stories?




















We will not share your e-mail address or other personal information.

Already subscribed? Manage your subscription.